Sofya Lebedeva, co-founder of ARMOR [Alliance for Reducing Microbial Resistance], has over 3 years of experience in the biosecurity space, and a PhD (in progress) in Clinical Medicine at Oxford. She will be working on this project part time, providing additional research capacity and helping facilitate connections in academia. She's half scientist, half entrepreneur, and all about positive impact.
Antimicrobial Resistance (AMR) poses a global health threat as microbes adapt to resist standard treatments. This presentation delineates the challenges and solutions, underscoring the imperative for innovative strategies to counter the overuse and misuse of antimicrobials. ARMoR, a non-profit, is actively contributing to the fight against AMR through evidence-driven research, advocacy, and strategic policy initiatives. Our focus centres on market-shaping “pull incentives” to facilitate new antimicrobial development. The presentation succinctly outlines ARMoR’s ongoing projects and invites potential collaboration.
Challenges to be solved:
- Better access to Antimicrobials in LMICs
- Better stewardship of Antimicrobials in LMICs
- A decent cost-benefit analysis of various pull incentives
- A <$5 test for sepsis
- A cheap point-of-care test to determine between bacterial vs viral
- Better modelling of novel resistance strains
- Better large-scale modelling of AMR